<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02070484</url>
  </required_header>
  <id_info>
    <org_study_id>OH2-13-0034</org_study_id>
    <nct_id>NCT02070484</nct_id>
  </id_info>
  <brief_title>Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease</brief_title>
  <official_title>Efficacy of a Human Amniotic Tissue-derived Allograft, NuCel, in Patients Undergoing Posteriolateral Lumbar Fusions for Degenerative Disc Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OhioHealth</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NuTech Medical, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>OhioHealth</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effect and safety of NuCel to DBX on patients
      undergoing posteriolateral lumbar spinal fusions for degenerative disc disease.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Poor enrollment
  </why_stopped>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">March 24, 2017</completion_date>
  <primary_completion_date type="Actual">March 24, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>12 months</time_frame>
    <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>Baseline</time_frame>
    <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>1 month</time_frame>
    <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>2 months</time_frame>
    <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>3 months</time_frame>
    <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>6 months</time_frame>
    <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Computed Tomography (CT) Scans to Assess Lumbar Bone Fusion</measure>
    <time_frame>6 and 12 months</time_frame>
    <description>CT scans reviewed by an independent radiologist and scored according to three categories: no fusion, any fusion, solid fusion.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Lumbar Degenerative Disc Disease</condition>
  <condition>Spinal Stenosis</condition>
  <condition>Spondylolisthesis</condition>
  <condition>Spondylosis</condition>
  <condition>Intervertebral Disk Displacement</condition>
  <condition>Intervertebral Disk Degeneration</condition>
  <condition>Spinal Diseases</condition>
  <condition>Bone Diseases</condition>
  <condition>Musculoskeletal Diseases</condition>
  <condition>Spondylolysis</condition>
  <arm_group>
    <arm_group_label>NuCel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stemcell allograft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Demineralized Bone Matrix (DBM)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Demineralized Bone Matrix (DBM) bone graft substitute</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>NuCel</intervention_name>
    <arm_group_label>NuCel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Demineralized Bone Matrix</intervention_name>
    <arm_group_label>Demineralized Bone Matrix (DBM)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between the ages of 18 and 75 years

          -  Symptomatic, single-level degenerative lumbar disc disease, spondylosis or
             spondylolisthesis

          -  Failed conservative treatments

          -  Low risk for non-union

          -  Must be candidates for single-level, posteriolateral lumbar spine fusion

          -  Must be able and willing to give Informed Consent

          -  English-speaking

        Exclusion Criteria:

          -  Smoker (any smoking â‰¤3 months prior to consent); (Patel et al. 2013)

          -  Patients with poorly controlled diabetes mellitus (HgbA1c &gt; 7%)

          -  Documented osteoporosis

          -  Prior lumbar spinal surgery at the same spinal level, or immediately adjacent spine
             level, to the level being operated on

          -  Back pain due to infection, tumour, or metabolic bone disease

          -  Terminal disease, such as HIV infection, neoplasm

          -  Autoimmune disease, such as rheumatoid arthritis

          -  Morbid obesity (body mass index (BMI) of 35 kg/m2)

          -  Major psychiatric illness in the last year

          -  History of alcohol or drug abuse in the last year

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Shehadi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OhioHealth</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Riverside Methodist Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grant Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>February 21, 2014</study_first_submitted>
  <study_first_submitted_qc>February 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2014</study_first_posted>
  <results_first_submitted>April 13, 2018</results_first_submitted>
  <results_first_submitted_qc>July 27, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">August 27, 2018</results_first_posted>
  <last_update_submitted>August 28, 2018</last_update_submitted>
  <last_update_submitted_qc>August 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>OhioHealth</investigator_affiliation>
    <investigator_full_name>Joseph A. Shehadi, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>NuCel</keyword>
  <keyword>Lumbar Spine</keyword>
  <keyword>Degenerative Disease</keyword>
  <keyword>Efficacy</keyword>
  <keyword>Fusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Spinal Diseases</mesh_term>
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
    <mesh_term>Bone Diseases</mesh_term>
    <mesh_term>Spondylolisthesis</mesh_term>
    <mesh_term>Spondylosis</mesh_term>
    <mesh_term>Intervertebral Disc Displacement</mesh_term>
    <mesh_term>Spondylolysis</mesh_term>
    <mesh_term>Musculoskeletal Diseases</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 24, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/84/NCT02070484/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>NuCel</title>
          <description>Stemcell allograft
NuCel</description>
        </group>
        <group group_id="P2">
          <title>Demineralized Bone Matrix (DBM)</title>
          <description>Demineralized Bone Matrix (DBM) bone graft substitute
Demineralized Bone Matrix</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>NuCel</title>
          <description>Stemcell allograft
NuCel</description>
        </group>
        <group group_id="B2">
          <title>Demineralized Bone Matrix (DBM)</title>
          <description>Demineralized Bone Matrix (DBM) bone graft substitute
Demineralized Bone Matrix</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="6"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Oswestry Disability Index</title>
          <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3"/>
                    <count group_id="B2" value="3"/>
                    <count group_id="B3" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.7" lower_limit="26" upper_limit="32"/>
                    <measurement group_id="B2" value="26.7" lower_limit="19" upper_limit="34"/>
                    <measurement group_id="B3" value="27.7" lower_limit="19" upper_limit="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Oswestry Disability Index</title>
        <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
        <time_frame>12 months</time_frame>
        <population>One of three NuCel patients withdrew before 12 months; therefore, analysis comprises two NuCel patients and three DBM patients.</population>
        <group_list>
          <group group_id="O1">
            <title>NuCel</title>
            <description>Stemcell allograft
NuCel</description>
          </group>
          <group group_id="O2">
            <title>Demineralized Bone Matrix (DBM)</title>
            <description>Demineralized Bone Matrix (DBM) bone graft substitute
Demineralized Bone Matrix</description>
          </group>
        </group_list>
        <measure>
          <title>Oswestry Disability Index</title>
          <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
          <population>One of three NuCel patients withdrew before 12 months; therefore, analysis comprises two NuCel patients and three DBM patients.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" spread="11.3"/>
                    <measurement group_id="O2" value="15.3" spread="17.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Computed Tomography (CT) Scans to Assess Lumbar Bone Fusion</title>
        <description>CT scans reviewed by an independent radiologist and scored according to three categories: no fusion, any fusion, solid fusion.</description>
        <time_frame>6 and 12 months</time_frame>
        <population>The study was terminated due to low enrollment; therefore, CT scans at 6 and 12 months were not conducted.</population>
        <group_list>
          <group group_id="O1">
            <title>NuCel</title>
            <description>Stemcell allograft
NuCel</description>
          </group>
          <group group_id="O2">
            <title>Demineralized Bone Matrix (DBM)</title>
            <description>Demineralized Bone Matrix (DBM) bone graft substitute
Demineralized Bone Matrix</description>
          </group>
        </group_list>
        <measure>
          <title>Computed Tomography (CT) Scans to Assess Lumbar Bone Fusion</title>
          <description>CT scans reviewed by an independent radiologist and scored according to three categories: no fusion, any fusion, solid fusion.</description>
          <population>The study was terminated due to low enrollment; therefore, CT scans at 6 and 12 months were not conducted.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Oswestry Disability Index</title>
        <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NuCel</title>
            <description>Stemcell allograft
NuCel</description>
          </group>
          <group group_id="O2">
            <title>Demineralized Bone Matrix (DBM)</title>
            <description>Demineralized Bone Matrix (DBM) bone graft substitute
Demineralized Bone Matrix</description>
          </group>
        </group_list>
        <measure>
          <title>Oswestry Disability Index</title>
          <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.7" spread="3.1"/>
                    <measurement group_id="O2" value="26.7" spread="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Oswestry Disability Index</title>
        <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
        <time_frame>1 month</time_frame>
        <population>One of three NuCel patients withdrew; therefore, analysis comprises two NuCel patients and three DBM patients.</population>
        <group_list>
          <group group_id="O1">
            <title>NuCel</title>
            <description>Stemcell allograft
NuCel</description>
          </group>
          <group group_id="O2">
            <title>Demineralized Bone Matrix (DBM)</title>
            <description>Demineralized Bone Matrix (DBM) bone graft substitute
Demineralized Bone Matrix</description>
          </group>
        </group_list>
        <measure>
          <title>Oswestry Disability Index</title>
          <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
          <population>One of three NuCel patients withdrew; therefore, analysis comprises two NuCel patients and three DBM patients.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.5" spread="12.0"/>
                    <measurement group_id="O2" value="26.7" spread="13.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Oswestry Disability Index</title>
        <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
        <time_frame>2 months</time_frame>
        <population>One of three NuCel patients withdrew; therefore, analysis comprises two NuCel patients and three DBM patients.</population>
        <group_list>
          <group group_id="O1">
            <title>NuCel</title>
            <description>Stemcell allograft
NuCel</description>
          </group>
          <group group_id="O2">
            <title>Demineralized Bone Matrix (DBM)</title>
            <description>Demineralized Bone Matrix (DBM) bone graft substitute
Demineralized Bone Matrix</description>
          </group>
        </group_list>
        <measure>
          <title>Oswestry Disability Index</title>
          <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
          <population>One of three NuCel patients withdrew; therefore, analysis comprises two NuCel patients and three DBM patients.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.5" spread="17.7"/>
                    <measurement group_id="O2" value="22.0" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Oswestry Disability Index</title>
        <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
        <time_frame>3 months</time_frame>
        <population>One of three NuCel patients withdrew; therefore, analysis comprises two NuCel patients and three DBM patients.</population>
        <group_list>
          <group group_id="O1">
            <title>NuCel</title>
            <description>Stemcell allograft
NuCel</description>
          </group>
          <group group_id="O2">
            <title>Demineralized Bone Matrix (DBM)</title>
            <description>Demineralized Bone Matrix (DBM) bone graft substitute
Demineralized Bone Matrix</description>
          </group>
        </group_list>
        <measure>
          <title>Oswestry Disability Index</title>
          <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
          <population>One of three NuCel patients withdrew; therefore, analysis comprises two NuCel patients and three DBM patients.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.0" spread="12.7"/>
                    <measurement group_id="O2" value="25.7" spread="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Oswestry Disability Index</title>
        <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
        <time_frame>6 months</time_frame>
        <population>One of three NuCel patients withdrew; therefore, analysis comprises two NuCel patients and three DBM patients.</population>
        <group_list>
          <group group_id="O1">
            <title>NuCel</title>
            <description>Stemcell allograft
NuCel</description>
          </group>
          <group group_id="O2">
            <title>Demineralized Bone Matrix (DBM)</title>
            <description>Demineralized Bone Matrix (DBM) bone graft substitute
Demineralized Bone Matrix</description>
          </group>
        </group_list>
        <measure>
          <title>Oswestry Disability Index</title>
          <description>The Oswestry Disability Index (ODI) measures disability on a scale of 0-100, where higher scores correspond to greater disability.</description>
          <population>One of three NuCel patients withdrew; therefore, analysis comprises two NuCel patients and three DBM patients.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" spread="9.2"/>
                    <measurement group_id="O2" value="14.7" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were recorded through 12 months post-operatively</time_frame>
      <group_list>
        <group group_id="E1">
          <title>NuCel</title>
          <description>Stemcell allograft
NuCel</description>
        </group>
        <group group_id="E2">
          <title>Demineralized Bone Matrix (DBM)</title>
          <description>Demineralized Bone Matrix (DBM) bone graft substitute
Demineralized Bone Matrix</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Prolonged hospitalization</sub_title>
                <description>Intermittent diarrhea, bloating, and stomach pain beginning post-operative day 5. Symptoms improved with bowel regimen and liquid diet; solid food resumed post-operative day 5. Patient discharged post-operative day 5.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Josepha Shehadi, MD</name_or_title>
      <organization>OhioHealth</organization>
      <phone>614-220-5648</phone>
      <email>joseph@drshehadi.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

